Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
MTEM
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct | 150,000 Added 1.58% |
$1,255,500
$8.37 p/Share
|
Apr 14
2021 |
GLSPT
|
Global Spac Partners Sponsor LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 15,000 Added 2.75% |
$150,000
$10.0 p/Share
|
Apr 14
2021 |
GLSPT
|
Bryant B Edwards
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 15,000 Added 2.75% |
$150,000
$10.0 p/Share
|
Apr 14
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 34 Added 0.26% |
$54,842
$1613.0 p/Share
|
Apr 14
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.26% |
$4,839
$1613.0 p/Share
|
Apr 14
2021 |
STON
|
Andrew Axelrod
Director |
BUY
Open market or private purchase
|
Indirect | 5,522,732 Added 5.87% |
$12,150,011
$2.2 p/Share
|
Apr 14
2021 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.17% |
$1,768
$2.62 p/Share
|
Apr 14
2021 |
LNDC
|
Albert D. Bolles
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 9,000 Added 16.62% |
$95,490
$10.61 p/Share
|
Apr 14
2021 |
LNDC
|
James G Hall
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 10,000 Added 20.35% |
$106,200
$10.62 p/Share
|
Apr 14
2021 |
LNDC
|
John D Morberg
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 2,000 Added 12.99% |
$21,280
$10.64 p/Share
|
Apr 14
2021 |
FRAF
|
Karen K Carmack
SVP, Chief HR Officer |
BUY
Open market or private purchase
|
Direct | 1 Added 0.06% |
$30
$30.31 p/Share
|
Apr 14
2021 |
FRAF
|
Ronald L Cekovich
SVP |
BUY
Open market or private purchase
|
Direct | 3 Added 0.04% |
$91
$30.31 p/Share
|
Apr 14
2021 |
FRAF
|
Mark R Hollar
EVP, CFO |
BUY
Open market or private purchase
|
Direct | 3 Added 0.05% |
$91
$30.31 p/Share
|
Apr 14
2021 |
XPL
|
James Kb Hesketh
Director |
BUY
Open market or private purchase
|
Direct | 25,000 Added 5.38% |
$7,750
$0.31 p/Share
|
Apr 14
2021 |
CRTD
|
Jeremy Frommer
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 1,000 Added 0.31% |
$4,250
$4.25 p/Share
|
Apr 14
2021 |
IMH
|
Rhp Trust, Dated May 31, 2011
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 12,970 Added 0.37% |
$25,292
$1.95 p/Share
|
Apr 14
2021 |
IMH
|
Richard H. Pickup
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 12,970 Added 0.37% |
$25,292
$1.95 p/Share
|
Apr 14
2021 |
JMP
|
Wedbush Securities Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 102 Added 0.0% |
$687
$6.74 p/Share
|
Apr 14
2021 |
JMP
|
Wedbush Securities Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 102 Added 0.0% |
$687
$6.74 p/Share
|
Apr 14
2021 |
STLY
|
Solas Capital Management, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 120,000 Added 0.85% |
$76,800
$0.64 p/Share
|
Apr 14
2021 |
MACK
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect | 47,300 Added 3.05% |
$313,599
$6.63 p/Share
|
Apr 14
2021 |
DXLG
|
Elaine Rubin
Director |
BUY
Open market or private purchase
|
Direct | 25,000 Added 50.0% |
$33,000
$1.32 p/Share
|
Apr 14
2021 |
DXLG
|
Elaine Rubin
Director |
BUY
Open market or private purchase
|
Indirect | 15,000 Added 50.0% |
$20,100
$1.34 p/Share
|
Apr 14
2021 |
AHT
|
Benjamin J Md Ansell
Director |
BUY
Open market or private purchase
|
Indirect | 50,000 Added 33.01% |
$107,500
$2.15 p/Share
|
Apr 14
2021 |
SLNG
|
Jch Crenshaw Holdings, LLC
Director |
BUY
Open market or private purchase
|
Direct | 50 Added 0.08% |
$325
$6.5 p/Share
|
Apr 14
2021 |
RFIL
|
Mark Keith Holdsworth
Director |
BUY
Open market or private purchase
|
Indirect | 4,700 Added 1.54% |
$32,853
$6.99 p/Share
|
Apr 14
2021 |
FMFG
|
Teresa L. Smack
Director |
BUY
Open market or private purchase
|
Direct | 875 Added 47.37% |
$17,448
$19.94 p/Share
|
Apr 14
2021 |
ACCR
|
Access Power & Co., Inc.
Director |
BUY
Open market or private purchase
|
Direct | 172,500 Added 0.09% |
$8,625
$0.05 p/Share
|
Apr 14
2021 |
INVO
|
Awm Investment Company, Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 17,152 Added 1.49% |
$67,750
$3.95 p/Share
|
Apr 14
2021 |
ACCR
|
Patrick J Jensen |
BUY
Open market or private purchase
|
Direct | 172,500 Added 0.09% |
$8,625
$0.05 p/Share
|
Apr 14
2021 |
LOV
|
John Hartnett Lewis
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 29,311 Added 10.38% |
$206,349
$7.04 p/Share
|
Apr 13
2021 |
NUVB
|
Oleg Nodelman
Director |
BUY
Open market or private purchase
|
Indirect | 31,500 Added 0.34% |
$323,505
$10.27 p/Share
|
Apr 13
2021 |
RFIL
|
Mark Keith Holdsworth
Director |
BUY
Open market or private purchase
|
Indirect | 25,000 Added 7.8% |
$173,000
$6.92 p/Share
|
Apr 13
2021 |
LNDC
|
John D Morberg
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 2,000 Added 14.93% |
$20,360
$10.18 p/Share
|
Apr 13
2021 |
TSI
|
Laird Landmann
PORTFOLIO MANAGER |
BUY
Open market or private purchase
|
Direct | 18,971 Added 2.83% |
$107,186
$5.65 p/Share
|
Apr 13
2021 |
IGXT
|
Dana Matzen
VP Business & Corp. Dev |
BUY
Open market or private purchase
|
Direct | 25,000 Added 50.0% |
$12,250
$0.49 p/Share
|
Apr 13
2021 |
LNDC
|
Wynnefield Partners Small Cap Value LP I
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,508 Added 0.14% |
$25,306
$10.09 p/Share
|
Apr 13
2021 |
SREV
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 18,504 Added 0.1% |
$25,721
$1.39 p/Share
|
Apr 13
2021 |
BWFG
|
James M Garnett Jr
Director |
BUY
Open market or private purchase
|
Indirect | 1 Added 0.02% |
$27
$27.45 p/Share
|
Apr 13
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 34 Added 0.26% |
$52,382
$1540.64 p/Share
|
Apr 13
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.26% |
$4,622
$1540.64 p/Share
|
Apr 13
2021 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.17% |
$1,735
$2.57 p/Share
|
Apr 13
2021 |
RPHM
|
Novo Holdings
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 666,666 Added 16.27% |
$9,999,990
$15.0 p/Share
|
Apr 13
2021 |
RAPT
|
Wendye Robbins |
BUY
Open market or private purchase
|
Direct | 700 Added 10.29% |
$13,615
$19.45 p/Share
|
Apr 13
2021 |
BWFG
|
Blake S Drexler
Director |
BUY
Open market or private purchase
|
Indirect | 389 Added 1.27% |
$10,678
$27.45 p/Share
|
Apr 13
2021 |
BWFG
|
Daniel S Jones
Director |
BUY
Open market or private purchase
|
Indirect | 193 Added 0.69% |
$5,298
$27.45 p/Share
|
Apr 13
2021 |
BWFG
|
Carl M Porto
Director |
BUY
Open market or private purchase
|
Indirect | 160 Added 1.47% |
$4,392
$27.45 p/Share
|
Apr 13
2021 |
BWFG
|
Eric J Dale
Director |
BUY
Open market or private purchase
|
Indirect | 216 Added 0.88% |
$5,929
$27.45 p/Share
|
Apr 13
2021 |
GLSI
|
Snehal Patel
CEO and CFO |
BUY
Open market or private purchase
|
Direct | 2,700 Added 0.23% |
$99,846
$36.98 p/Share
|
Apr 13
2021 |
SNSE
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.04% |
$28,000
$14.0 p/Share
|
Apr 13
2021 |